EPO Patent Publication EP2026028952A1: Synthetic Protein and Related Compositions
Summary
The European Patent Office has published patent application EP2026028952A1 concerning synthetic proteins, complexes, compositions, polynucleotides, expression vectors, and pharmaceutical compositions. The publication date is March 18, 2026, and it covers various applications including osteogenesis, cartilage proliferation, and angiogenesis promotion.
What changed
The European Patent Office (EPO) has published patent application EP2026028952A1, detailing inventions related to synthetic proteins, complexes, compositions, polynucleotides, expression vectors, transformants, and pharmaceutical compositions. The application, published on March 18, 2026, includes classifications for protein chemistry, pharmaceutical preparations, and molecular biology techniques.
This publication represents a new patent filing and does not impose immediate compliance obligations on regulated entities. However, it is relevant for companies operating in the biotechnology and pharmaceutical sectors involved in research, development, and intellectual property management. Companies should monitor the progress of this patent application and similar filings for potential impacts on their product development and market strategies.
Source document (simplified)
SYNTHETIC PROTEIN, COMPLEX, COMPOSITION, POLYNUCLEOTIDE, EXPRESSION VECTOR, TRANSFORMANT, OSTEOGENESIS PROMOTER, CARTILAGE PROLIFERATION PROMOTER, ANGIOGENESIS PROMOTER, AND PHARMACEUTICAL COMPOSITION
Publication EP2026028952A1 Kind: A1 Mar 18, 2026
Inventors
The designation of the inventor has not yet been filed
IPC Classifications
C07K 19/00 20060101AFI20260207BHEP A61K 38/16 20060101ALI20260207BHEP A61K 38/22 20060101ALI20260207BHEP A61K 38/39 20060101ALI20260207BHEP A61P 9/00 20060101ALI20260207BHEP A61P 19/00 20060101ALI20260207BHEP A61P 19/08 20060101ALI20260207BHEP C07K 14/78 20060101ALI20260207BHEP C12N 1/15 20060101ALI20260207BHEP C12N 1/19 20060101ALI20260207BHEP C12N 1/21 20060101ALI20260207BHEP C12N 5/10 20060101ALI20260207BHEP C12N 15/62 20060101ALI20260207BHEP C07K 14/33 20060101ALI20260207BHEP C07K 14/575 20060101ALI20260207BHEP C12N 15/16 20060101ALI20260207BHEP C12N 15/31 20060101ALI20260207BHEP C12N 15/63 20060101ALI20260207BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Named provisions
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: EPO Bulletin - Biotech (C12N) publishes new changes.